Randal W. Scott

CIK 1337801 · Executive Chairman · last filed 2026-05-19

Randal W. Scott is an Executive Chairman who has filed 114 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for BBIO, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$21.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.66M

Companies

4

Total Filings

114

Lifetime Open-Market Net

-$21.28M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBIO Director 19,389 $85.55 $1.66M -$1.48M 15 2026-05-19
Talis Biomedical Corp (TLIS) Delisted Director 21,433 $2.84 $60.9K $5.20M 4 2023-06-12
Invitae Corp (NVTA) Delisted Executive Chairman 221,222 $0.09 $19.7K -$1.48M 11 2023-05-01
GENOMIC HEALTH INC (GHDX) Delisted CEO, InVitae Corporation* 1,188,883 -$23.52M 77 2012-07-12

Recent Filings

114 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 BBIO Notice (144) −2,196 -$150.7K EDGAR
2026-05-19 BBIO Mixed -$504.0K EDGAR
2026-02-18 BBIO Mixed -$587.1K EDGAR
2026-02-17 BBIO Notice (144) −20,000 -$1.50M EDGAR
2025-11-19 BBIO Mixed -$499.0K EDGAR
2025-11-17 BBIO Notice (144) −10,000 -$663.9K EDGAR
2025-06-24 BBIO Grant (A) +6,589 $0 EDGAR
2024-06-25 BBIO Grant (A) $0 EDGAR
2024-06-05 BBIO Sell (S) −2,500 -$75.8K EDGAR
2024-06-03 BBIO Notice (144) −2,500 -$70.0K EDGAR
Showing 110 of 114
Page 1 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.